In a report released yesterday, Christopher Glynn from Oppenheimer assigned a Buy rating to Acuity Brands (AYI), with a price target of $205.00.

RBC Capital analyst Wayne Lam maintained a Buy rating on Roxgold (ROGFF) on April 16 and set a price target of C$2.25.

In a report issued on April 12, Matt Phipps from William Blair reiterated a Buy rating on Codiak BioSciences (CDAK). The company’s shares …

Oppenheimer analyst Scott Schneeberger maintained a Hold rating on United Rentals (URI) today. The company’s shares closed last Thursday at $325.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vir Biotechnology (VIR) and Xenon …

In a report released today, Ram Selvaraju from H.C.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bausch Health Companies (BHC), Arcus …

In a report released today, Michael Matson from Needham assigned a Buy rating to NeoGenomics (NEO), with a price target of $65.00.

There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Sarepta Therapeutics (SRPT) with …

In a report released today, Heiko Ihle from H.C.